Back to Search Start Over

Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.

Authors :
Lee CH
Yogesh Shah A
Rao A
Taylor MH
Di Simone C
Hsieh JJ
Pinto A
Gironés Sarrió R
Lee Cohn A
Asim Bilen M
Gunnestad Ribe S
Krohn Tennøe Ø
Richards D
Sweis RF
Courtright J
Heinrich D
Perini R
Kubiak P
Bock D
Okpara CE
Motzer RJ
Source :
European urology [Eur Urol] 2024 Nov; Vol. 86 (5), pp. 470-473. Date of Electronic Publication: 2024 May 21.
Publication Year :
2024

Details

Language :
English
ISSN :
1873-7560
Volume :
86
Issue :
5
Database :
MEDLINE
Journal :
European urology
Publication Type :
Editorial & Opinion
Accession number :
38777648
Full Text :
https://doi.org/10.1016/j.eururo.2024.05.003